In-vitro susceptibility of organisms isolated from burns to topical co-trimoxazole.
D000287:Administration, Topical; D001419:Bacteria / Q000187:drug effects*; D002056:Burns / Q000382:microbiology*; D004338:Drug Combinations / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000494:pharmacology*; D014295:Trimethoprim / Q000008:administration & dosage / Q000494:pharmacology*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole